Cannabis is a widely used drug like tobacco and alcohol. In the meantime, it is also prescribed for medical treatment in some countries. Tobacco smoke contains chemical carcinogens and particulate matter (PM) that are both harmful to health.
Method:
In this study, we investigated PM levels in second-hand smoke (SHS) of hand-tamped cannabis cigarettes compared to cigarettes with tubing tobacco and the 3R4F reference cigarette.
Results:
It could be demonstrated that the largest proportion of the particle mass is attributable to particles with a diameter of less than 1μm and that every tested cigarette emitted more PM than the 3R4F reference cigarette. In addition, our data clearly revealed that cannabis smoke contains higher PM levels in SHS than tobacco cigarettes. Compared to the reference cigarette, the PM1 emissions of cannabis were 105% higher. Also, the cannabis mixed cigarettes had higher PM levels than the 3R4F cigarettes. For instance, the PM10 emissions were 93% higher. Also, the Gauloises Mélange tubing tobacco also reached higher PM concentrations than the 3R4F cigarette.
Discussion:
Regardless of negative health effects, cannabis is seen as a harmless drug in the public eye. We found strong indications for potential health risks by PM from cannabis products and, therefore, the public should be educated about a potential harm.
Get full access to this article
View all access options for this article.
References
1.
United Nations Office on Drugs and Crime (UNODC). World Drug Report 2018—Booklet 4: Drugs and Age. UNODC: Vienna, Austria; 2018.
2.
PaculaRL, SmartR. Medical marijuana and marijuana legalization. Annu Rev Clin Psychol, 2017; doi: 10.1146/annurev-clinpsy-032816
3.
MaertensRM, WhitePA, WilliamsA, et al.A global toxicogenomic analysis investigating the mechanistic differences between tobacco and marijuana smoke condensates in vitro. Toxicology, 2013; 308:60–73; doi: 10.1016/j.tox.2013.03.008
4.
TomarRS, BeaumontJ, HsiehJCY. Evidence on the Carcinogenicity of Marijuana Smoke. Reproductive and Cancer Hazard Assessment Branch Office of Environmental Health Hazard Assessment. California Environmental Protection Agency: Sacramento, CA;, 2009;(August); p. 2.
5.
SwiftW, CoffeyC, DegenhardtL, et al.Cannabis and progression to other substance use in young adults: Findings from a 13-year prospective population-based study. J Epidemiol Community Health, 2012; 66(7):6–11; doi: 10.1136/jech.2010.129056
6.
WeierM, ChanGCK, QuinnC, et al.Cannabis use in 14 to 25 year old Australians 1998 to 2013. Centre for Youth Substance Abuse Research: Brisbane;, 2016; doi: 10.13140/RG.2.1.4961.3680
7.
The Federal Government Commissioner for Drugs. Federal Ministry of Health [in German]. Drogen- Und Suchtbericht. Berlin; 2018.
8.
The German Ministry of Justice, Bundesanzeiger Verlag. Act amending narcotics law and other regulations [in German]. Köln; 2017.
9.
Krcevski-SkvarcN, WellsC, HäuserW. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation. Eur J Pain (United Kingdom), 2018; 22(3):440–454; doi: 10.1002/EJP.1147
10.
MaroonJ, BostJ. Review of the neurological benefits of phytocannabinoids. Surg Neurol Int, 2018; 9(91); doi: 10.4103/SNI.SNI_45_18
11.
MackieK. Mechanisms of CB1 receptor signaling: Endocannabinoid modulation of synaptic strength. Int J Obes, 2006; 30(1):S19–S23; doi: 10.1038/sj.ijo.0803273
12.
ChiouLC, HuSSJ, HoYC. Targeting the cannabinoid system for pain relief?. Acta Anaesthesiol Taiwan, 2013; 51(4):161–170; doi: 10.1016/J.AAT.2013.10.004
13.
World Health Organization. The Health and Social Effects of Nonmedical Cannabis Use. WHO: Geneva, Switzerland; 2016.
14.
HartS, OliverMF, AxelU. Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha—converting enzyme (TACE/ADAM17)—mediated transactivation of the epidermal growth factor receptor. Cancer Res, 2004; 64(6):1943–1950; doi: 10.1158/0008-5472
15.
LaroseY, MaertensR, DesjardinsS, et al.A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol, 2007; 21(2):494–502; doi: 10.1021/tx700275p
16.
U.S. Department of Health and Human Services. Executive Summary: The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. U.S. Department of Health and Human Services: Rockville, MD, USA; 2014.
The American Cancer Society medical and editorial content team. Health Risks of Secondhand Smoke. The American Cancer Society medical and editorial content team: Atlanta, GA, USA; 2015.
19.
Pope IIICA. Epidemiology of fine particulate air pollution and human health: Biologic mechanisms and who's at risk?. Environ Health Perspect, 2000; 108(Suppl. 4):713–723; doi: 10.1289/ehp.00108s4713
KimK-H, KabirE, KabirS. A review on the human health impact of airborne particulate matter. Environ Int, 2015; 74:136–143; doi: 10.1016/j.envint.2014.10.005
24.
SiponenT, Yli-TuomiT, AurelaM, et al.Source-specific fine particulate air pollution and systemic inflammation in ischaemic heart disease patients. Occup Environ Med, 2015; 72(4):277–283; doi: 10.1136/oemed-2014-102240
25.
BrookRD, RajagopalanS, PopeCA, et al.Particulate matter air pollution and cardiovascular disease. Circulation, 2010; 121(21):2331–2378; doi: 10.1161/CIR.0B013E3181DBECE1
26.
WangF, LiuJ, ZengH. Interactions of particulate matter and pulmonary surfactant: Implications for human health. Adv Colloid Interface Sci, 2020; 284:102244; doi: 10.1016/J.CIS.2020.102244
27.
GravesBM, JohnsonTJ, NishidaRT, et al.Comprehensive characterization of mainstream marijuana and tobacco smoke. Sci Rep, 2020; 1(10); doi: 10.1038/s41598-020-63120-6
28.
Anonymous. Cannabis Products by Bedrocan—for Patients and Medicine Development. n.d. Available from: bedrocan.com/products-services/ [Last accessed: April11, 2022].
MuellerD, SchulzeJ, AckermannH, et al.Particulate matter (PM) 2.5 levels in ETS emissions of a Marlboro Red cigarette in comparison to the 3R4F reference cigarette under open- and closed-door condition. J Occup Med Toxicol, 2012; 7(1):14; doi: 10.1186/1745-6673-7-14
32.
World Health Organization. Standard Operating Procedure for Intense Smoking of Cigarettes. WHO: Geneva, Switzerland; 2012.
33.
GerlachG, BraunM, DrögeJ, et al.Do budget cigarettes emit more particles? An aerosol spectrometric comparison of particulate matter concentrations between private-label cigarettes and more expensive brand-name cigarettes. Int J Environ Res Public Health, 2022; 19(5920).
34.
GerberA, Hofen-HohlochAV, SchulzeJ, et al.Tobacco smoke particles and indoor air quality (ToPIQ-II)—a modified study protocol and first results. J Occup Med Toxicol, 2015; 10(5); doi: 10.1186/s12995-015-0047-8
35.
McclureEA, StitzerML, VandreyR. Characterizing smoking topography of cannabis in heavy users. Psychopharmacology (Berl), 2013; 220(2):309–318; doi: 10.1007/s00213-011-2480-4
36.
SimmonsMS, TashkinDP. The relationship of tobacco and marijuana smoking characteristics. Life Sci, 1995; 56(23–24):2185–2191; doi: 10.1016/0024-3205(95)00206-L
37.
WUT-C, TashkinDP, DjahedB, et al.Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med, 1988; 318(6):347–351; doi: 10.1056/NEJM198802113180603
MuellerD, UibelS, BraunM, et al.Tobacco Smoke Particles and Indoor Air Quality (ToPIQ)—the protocol of a new study. J Occup Med Toxicol, 2011; doi: 10.1186/1745-6673-6-35
40.
BraunM, DehmM, KlingelhöferD, et al.High particulate matter burden by cigarillos: A laser spectrometric analysis of second-hand smoke of common brands with and without filter. PLoS One, 2021; 16(7); doi: 10.1371/JOURNAL.PONE.0254537
41.
BraunM, MarsidiL, KlingelhöferD, et al.Kretek cigarettes and particulate matter emissions—an aerosol spectrometric study on typical Indonesian brands flavored with cloves. Nicotine Tob Res, 2021 [Published online ahead of print].
42.
RustemeierK, StabbertR, HaussmannH-J, et al.Evaluation of the potential effects of ingredients added to cigarettes. Part 2: Chemical composition of mainstream smoke. Food Chem Toxicol, 2002; 40(1):93–104; doi: 10.1016/S0278-6915(01)00085-0
43.
BraunM, KogerF, KlingelhöferD, et al.Particulate matter emissions of four different cigarette types of one popular brand: Influence of tobacco strength and additives. Int J Environ Res Public Health, 2019; 16(2):263; doi: 10.3390/ijerph16020263
44.
BraunM, FrommE-L, GerberA, et al.Particulate matter emissions of four types of one cigarette brand with and without additives: A laser spectrometric particulate matter analysis of secondhand smoke. BMJ Open, 2019; 9; doi: 10.1136/bmjopen-2018-024400
45.
PopeCA, ThunMJ, NamboodiriMM, et al.Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med, 1995; 151(3 I):669–674; doi: 10.1164/ajrccm.151.3.7881654
46.
IshidaJH, ZhangAJ, SteigerwaldS, et al.Sources of information and beliefs about the health effects of marijuana. J Gen Intern Med, 2020; 35(1):153–159; doi: 10.1007/S11606-019-05335-6/TABLES/4
47.
SinclairCF, FousheeHR, ScarinciI, et al.Perceptions of harm to health from cigarettes, blunts, and marijuana among young adult African American men. J Health Care Poor Underserved, 2013; 24(3):1266–1275; doi: 10.1353/HPU.2013.0126
48.
KeyhaniS, SteigerwaldS, IshidaJ, et al.Risks and benefits of marijuana use: A national survey of U.S. adults. Ann Intern Med, 2018; 169(5):282–290; doi: 10.7326/M18-0810
49.
NguyenPK, HammondSK. Fine particulate matter exposure from secondhand cannabis bong smoking. JAMA Netw Open, 2022; doi: 10.1001/jamanetworkopen.2022.4744
50.
OttWR, WallaceLA, ChengKC, et al.Measuring PM2.5 concentrations from secondhand tobacco vs. marijuana smoke in 9 rooms of a detached 2-story house. Sci Total Environ, 2022; 852; doi: 10.1016/J.SCITOTENV.2022.158244
51.
SheehanTJ, HamnettHJ, BeasleyR, et al.Chemical and physical variations of cannabis smoke from a variety of cannabis samples in New Zealand. Forensic Sci Res, 2018; 4(2):168–178; doi: 10.1080/20961790.2018.1445937
SempleS, LatifN. How long does secondhand smoke remain in household air: Analysis of PM 2.5 data from smokers' homes. Nicotine Tob Res, 2014; 16(10):1365–1370; doi: 10.1093/ntr/ntu089
54.
WilsonIS, RitchieD, AmosA, et al.“I'm not doing this for me”: Mothers' accounts of creating smoke-free homes. Health Educ Res, 2013; 28(1):165–178; doi: 10.1093/HER/CYS082
55.
FairchildAL, BayerR, LeeJS. The E-cigarette debate: What counts as evidence?. Am J Public Health, 2019; 109:1000–1006; doi: 10.2105/AJPH.2019.305107
56.
National Academies ofSciences, Engineering andMedicine. Public Health Consequences of E-Cigarettes. The National Academies Press: Washington, DC; 2018; doi: 10.17226/24952
57.
MurphyMB, HuangAS, SchickSF. PM2.5 concentrations in a cannabis store with on-site consumption. Environ Health Perspect, 2021; 129(6); doi: 10.1289/EHP8689
58.
PascualA.Medical Cannabis in Europe: The Markets & Opportunities. Marijuana Business Daily International: Lakewood, CO, USA; 2020.
59.
NaftaliT, DorM. Cannabis for the treatment of inflammatory bowel disease: A true medicine or a false promise?. Rambam Maimonides Med J, 2020; 11(1):4–4; doi: 10.5041/RMMJ.10390
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
